Pathway for EDRN Investigators in FDA Pre-Submission for Early Detection Studies

EDRN investigators can approach the FDA for pre-submission without an industry partner for proposed early detection study designs. The process involves validation, verification, and discovery stages in the biomarker pipeline, utilizing various technologies and biospecimen sets. An example from the o

0 views • 18 slides